To address the challenges of detecting pancreatic cancer early, Human Longevity, Inc is adding a new blood test to its prevention program. The test analyses DNA markers in the blood to identify cancer in its earliest stage—when treatment is most effective. It’s intended for high-risk groups like older adults with new-onset diabetes or a family history of the disease.